SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IMMUNOMEDICS
(NQNM:IMMU Last Sale: 31.68 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (IMMU : $31.68)
$6,777,287 million Market Cap at Market Close, July 1, 2022
Employs 115.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

300 American Road Research Report Earnings Snapshot - Last 11/05/18
Morris Plains, NJ 07950 Fact Sheet
Phone: (973) 605-8200 Financial Statements
Peer Comparison
Annual Reports

D.M. Goldenberg, Chmn., C.L. Sullivan, CEO, Gerard G. Gorman, CFO.
Researches and develops proprietary medical products which detect, diagnose, and treat cancer, infectious diseases, and immunological diseases.
Historical Charts    Technical Analysis
No Historical Data available for IMMU

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common IMMU $31.68 $31.68 0 .0 $29.82 $31.71 4,810,778 $29.82 $31.71 213,929,505
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
21-JUN-85 IMMU Split 2 for 1

A746
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex